![Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group unnamed unnamed](https://clinicalvalue.com/wp-content/uploads/2023/04/unnamed.jpg)
19 May 2023
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
These recommendations provide a critical guidance from NGS panel testing to final treatment decision based on MTB discussion.
READ MORE